Part 2/9:
The story begins with a 45-year-old male, known only as Jack, who faces a mix of reluctance and curiosity as he is invited to participate in an experimental clinical trial. His friend, eager to sell him on the potential benefits, encourages him to see the trial as a way to not only improve his health but possibly help others in similar predicaments. The promise of a revolutionary drug, codenamed Obsidian, teases improvements in the treatment of scars and tissue damage. Jack's hesitations reveal the moral ambiguity surrounding these trials, particularly when discussing the inherent risks and benefits.